DE1443315C3 - Cyclisches Polypeptid und Verfahren zu dessen Herstellung und dieses ent haltendes Mittel - Google Patents
Cyclisches Polypeptid und Verfahren zu dessen Herstellung und dieses ent haltendes MittelInfo
- Publication number
- DE1443315C3 DE1443315C3 DE1443315A DE1443315A DE1443315C3 DE 1443315 C3 DE1443315 C3 DE 1443315C3 DE 1443315 A DE1443315 A DE 1443315A DE 1443315 A DE1443315 A DE 1443315A DE 1443315 C3 DE1443315 C3 DE 1443315C3
- Authority
- DE
- Germany
- Prior art keywords
- cys
- phe
- giy
- asp
- ecm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title description 6
- 229920001184 polypeptide Polymers 0.000 title description 5
- 102000004196 processed proteins & peptides Human genes 0.000 title description 5
- 238000000034 method Methods 0.000 title description 3
- 125000004122 cyclic group Chemical group 0.000 title 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 7
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 6
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- RVQDZELMXZRSSI-IUCAKERBSA-N Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 RVQDZELMXZRSSI-IUCAKERBSA-N 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- NMWZMKLDGZXRKP-BZSNNMDCSA-N Cys-Phe-Phe Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NMWZMKLDGZXRKP-BZSNNMDCSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 150000001540 azides Chemical class 0.000 description 3
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- VSDUZFOSJDMAFZ-VIFPVBQESA-N methyl L-phenylalaninate Chemical compound COC(=O)[C@@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-VIFPVBQESA-N 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000007483 tonsillectomy Methods 0.000 description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 2
- IDZDFWJNPOOOHE-KKUMJFAQSA-N Cys-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N IDZDFWJNPOOOHE-KKUMJFAQSA-N 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- XAFGXFWSQCIECZ-UHFFFAOYSA-N N(=O)O.[N-]=[N+]=[N-].[Na+] Chemical compound N(=O)O.[N-]=[N+]=[N-].[Na+] XAFGXFWSQCIECZ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- JKRHDMPWBFBQDZ-UHFFFAOYSA-N n'-hexylmethanediimine Chemical compound CCCCCCN=C=N JKRHDMPWBFBQDZ-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH7616959A CH376125A (de) | 1959-07-24 | 1959-07-24 | Verfahren zur Herstellung eines bisher unbekannten Polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE1443315A1 DE1443315A1 (de) | 1969-11-20 |
| DE1443315B2 DE1443315B2 (de) | 1973-05-10 |
| DE1443315C3 true DE1443315C3 (de) | 1973-11-29 |
Family
ID=4534734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1443315A Expired DE1443315C3 (de) | 1959-07-24 | 1960-07-21 | Cyclisches Polypeptid und Verfahren zu dessen Herstellung und dieses ent haltendes Mittel |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3232923A (en:Method) |
| CH (1) | CH376125A (en:Method) |
| DE (1) | DE1443315C3 (en:Method) |
| ES (1) | ES259803A1 (en:Method) |
| FR (1) | FR726M (en:Method) |
| GB (1) | GB928607A (en:Method) |
| OA (1) | OA01257A (en:Method) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1193509B (de) * | 1960-06-02 | 1965-05-26 | Hoechst Ag | Verfahren zur Herstellung eines neuen Oktapeptids mit vasopressorischer Wirksamkeit |
| US4093610A (en) * | 1977-01-31 | 1978-06-06 | American Home Products Corporation | Process for producing triglycyl-lysine vasopressin and intermediates therefor |
-
1959
- 1959-07-24 CH CH7616959A patent/CH376125A/de unknown
-
1960
- 1960-06-13 GB GB20707/60A patent/GB928607A/en not_active Expired
- 1960-06-13 US US35460A patent/US3232923A/en not_active Expired - Lifetime
- 1960-07-21 DE DE1443315A patent/DE1443315C3/de not_active Expired
- 1960-07-22 ES ES0259803A patent/ES259803A1/es not_active Expired
- 1960-10-21 FR FR841872A patent/FR726M/fr active Active
-
1964
- 1964-12-31 OA OA51504A patent/OA01257A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH376125A (de) | 1964-03-31 |
| ES259803A1 (es) | 1960-10-16 |
| DE1443315B2 (de) | 1973-05-10 |
| GB928607A (en) | 1963-06-12 |
| DE1443315A1 (de) | 1969-11-20 |
| FR726M (en:Method) | 1961-08-07 |
| OA01257A (fr) | 1969-01-25 |
| US3232923A (en) | 1966-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1643273C3 (de) | Antidiuretisch wirksames Polypeptid und Verfahren zu seiner Herstellung | |
| DE2435027C2 (de) | Nonapeptidamide und Verfahren zu ihrer Herstellung | |
| EP0019115B1 (de) | Pankreozymin-Cholezystokinin aktive Peptide, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| DE1196666B (de) | Verfahren zur Herstellung neuer adrenocorticotrop wirksamer Tetracosapeptide | |
| DE2905502A1 (de) | Verfahren zur herstellung von lh-rh und lh-rh-analoga unter verwendung von pyro-glu-his(dnp)-oh | |
| DE2528935C2 (de) | Verfahren zur Herstellung Arginylreste enthaltender Peptide und hierbei eingesetzte Zwischenprodukte | |
| DE1518318C3 (de) | Desamino hoch 1 -Arg hoch 8 -Vasopressin | |
| DE1443315C3 (de) | Cyclisches Polypeptid und Verfahren zu dessen Herstellung und dieses ent haltendes Mittel | |
| DE1193509B (de) | Verfahren zur Herstellung eines neuen Oktapeptids mit vasopressorischer Wirksamkeit | |
| DE1518274C3 (de) | Phe hoch 2 -Orn hoch 8 -Vasopressin und Verfahren zu dessen Herstellung | |
| DE2003421A1 (de) | Verfahren zur Herstellung eines bisher unbekannten Polypeptids | |
| DE1518282C3 (de) | Phe hoch 2 -Om hoch 8 -Oxytocin und Verfahren zu dessen Herstellung | |
| DE1205546B (de) | Verfahren zur Herstellung neuer Dekapeptide | |
| DE2347456A1 (de) | Polypeptide und verfahren zu deren herstellung | |
| AT223754B (de) | Verfahren zur Herstellung eines bisher unbekannten Polypeptides | |
| CH437337A (de) | Verfahren zur Herstellung von Peptiden | |
| DE1965101A1 (de) | Pentadekapeptide mit adrenocorticotroper Wirkung und Verfahren zu ihrer Herstellung | |
| DE2817208A1 (de) | Geschuetzte aminosaeuren oder peptide | |
| AT249282B (de) | Verfahren zur Herstellung neuer Heneikosapeptide | |
| DE1493559C3 (de) | Neue Peptide mit adrenocorticotroper Wirkung und Verfahren zu ihrer Herstellung | |
| CH426862A (de) | Verfahren zur Herstellung eines bisher unbekannten Polypeptids | |
| DE1917690B2 (de) | Verfahren zur herstellung von peptiden | |
| DE1214242B (de) | Verfahren zur Herstellung eines Tetracosapeptides | |
| CH608788A5 (en) | Process for the preparation of novel peptides having a high adrenocorticotropic action | |
| CH541542A (de) | Verfahren zur Herstellung eines neuen Polypeptidamids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SH | Request for examination between 03.10.1968 and 22.04.1971 | ||
| C3 | Grant after two publication steps (3rd publication) | ||
| E77 | Valid patent as to the heymanns-index 1977 |